Gyre Therapeutics, Inc. (GYRE)

Gyre Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	57.35	52.43	26.67	33.51	25.18	44.35
Short-Term Investments	17.45	-	-	-	-	2.5
Cash & Short-Term Investments	74.8	52.43	26.67	33.51	25.18	46.85
Cash Growth	37.58%	96.56%	-20.41%	33.10%	-46.27%	-40.96%
Accounts Receivable	27.76	31.08	19.59	15.16	17.14	1.82
Other Receivables	0.49	5.87	9.56	1.68	-	-
Total Trade Receivables	28.25	36.95	29.15	16.84	17.14	1.82
Inventory	-	-	-	4.28	6.12	-
Other Current Assets	7.6	2.83	2.63	2.59	1.22	2.81
Total Current Assets	122.07	102.37	64.79	57.22	49.65	51.48
Net Property, Plant & Equipment	27.28	24.73	25.7	23.76	18.38	3.71
Other Intangible Assets	4.53	4.73	0.27	0.21	0.3	-
Other Long-Term Assets	45.37	34.31	34.65	11.91	16.43	0.47
Total Assets	199.26	166.13	125.41	116.54	84.75	55.66
Accounts Payable	1.24	0.12	0.11	0.36	0.12	6.42
Accrued Expenses	18.81	14.35	10.62	11.94	9.26	5.54
Current Portion of Leases	1.39	0.64	0.71	0.21	0.49	1.98
Unearned Revenue	-	0.01	0.06	0.04	0.15	0.23
Other Current Liabilities	7.23	3.17	8.02	7.51	2.22	-
Total Current Liabilities	28.66	18.29	19.52	20.05	12.24	14.17
Long-Term Leases	2.03	0.3	0.89	0.2	0.12	0.41
Other Long-Term Liabilities	3.64	5.26	6.6	17.82	0.17	-
Total Long-Term Liabilities	5.67	5.56	7.49	18.02	0.29	0.41
Total Liabilities	34.34	23.85	27	38.07	12.54	14.57
Preferred Stock	22.43	-	-	-	-	-
Common Stock	0.11	0.09	0.09	0.08	0.06	0.03
Additional Paid-in Capital	240.64	172.05	136.19	68.18	32.8	443.75
Accumulated Other Comprehensive Income	1.49	-0.78	-2.6	-1.64	-0.39	-
Retained Earnings	-134.31	-65.33	-70.36	-82.44	10.06	-402.69
Total Common Shareholders' Equity	130.36	106.03	63.32	-15.83	42.52	41.09
Minority Interest	34.56	36.25	35.08	94.3	29.7	-
Shareholders' Equity	142.49	142.28	98.4	13.95	72.22	41.09
Total Liabilities & Equity	199.26	166.13	125.41	116.54	84.75	55.66
Total Debt	3.42	0.94	1.6	0.41	0.61	2.39
Net Cash (Debt)	71.38	51.49	25.07	33.1	24.56	44.47
Net Cash Growth	34.75%	105.34%	-24.25%	34.76%	-44.76%	-42.78%
Net Cash Per Share	0.74	0.50	0.24	0.50	0.33	0.67
Book Value	130.36	106.03	63.32	-15.83	42.52	41.09
Book Value Per Share	1.35	1.03	0.62	-0.24	0.56	0.62
Tangible Book Value	125.83	101.3	63.05	-16.03	42.23	41.09
Tangible Book Value Per Share	1.30	0.98	0.62	-0.24	0.56	0.62

SEC Filings: 10-K · 10-Q

Data Source: Fiscal.ai Last updated: Aug 7, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 10, 2026

Data Sources Report a data error